EANS-News: Semperit AG Holding / Successful Start in 2016

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

quarterly report

- Semperit slightly increases revenue to EUR 219.5 million in Q1 2016
- EBITDA (+22.3%) and EBIT (+22.2%) significantly higher
- Good order situation despite continuous difficult market environment

The publicly listed Semperit Group showed a positive revenue and
earnings development in the first quarter of 2016 in spite of the
ongoing difficult market environment. Revenue rose slightly by 0.9%
to EUR 219.5 million (after EUR 217.5 million in Q1 2015) despite
negative price effects for raw material. Semperit improved the
group's EBITDA by 22.3% to EUR 26.7 million (after EUR 21.8 million).
EBIT increased by 22.2% to EUR 18.6 million (after EUR 15.2 million).
The EBITDA margin and the EBIT margin rose to 12.2% (after 10.0%) and
8.5% (after 7.0%) respectively.

This growth in earnings can be attributed to both the Industrial and
the Medical Sector. The Industrial Sector achieved further growth in
sales and profitability despite the weak economy. The continuation of
the structural and process optimisation in the Medical Sector had a
positive impact on results.

"In the first quarter of 2016 we showed a positive performance
contrary to the weak market. This was due to a continuing improvement
of our global presence as well as the capacity expansion in all
segments. Even our additional capacities are well utilised thanks to
our focused sales strategy, which had a positive effect on our
profitability," CEO Thomas Fahnemann summarised.

Semperit boasted a sound capital basis as reflected by its equity
ratio of 39.4% at the reporting date of March 31, 2016 (December 31,
2015: 38.7%). Cash and cash equivalents amounted to EUR 121.3 million
on 31 March 2016 compared to EUR 126.4 million at the end of 2015.
"With our good equity ratio and our attractive cash flow, our future
growth activities are financially well secured," states Semperit CFO
Johannes Schmidt-Schultes.

Industrial Sector: Significant increase in revenue and earnings The
Industrial Sector (Semperflex, Sempertrans and Semperform segments)
showed a very satisfying development contrary to the market trend.

The Semperflex segment generated continuing high profitability thanks
to excellent production and sales performances in a declining market.
In the Sempertrans segment, the global sales initiative led to
significant increases in revenue and earnings in a generally
stagnating market. In a difficult market environment, the Semperform
segment profited from the successful integration of the German
profile manufacturer Leeser as well as the increase in market share
in the handrail business.

Revenue of the Industrial Sector rose 6.0% to EUR 133.6 million in
the first quarter of 2016. EBITDA climbed 13.7% to EUR 25.1 million.

Medical Sector: Improved profitability In the Medical Sector
(Sempermed segment), process optimisations and efficiency
enhancements started in 2015 led to a significant improvement of
profitability. This was offset by negative price effects due to lower
raw material prices as well as partly negative impacts due to the
aggravated cooperation with the joint venture partner in Thailand.

Revenue of the Medical Sector decreased by 6.0% to EUR 85.9 million
in the first quarter of 2016 due to heavy price pressure and the
focus on high-margin customer relationships. EBITDA improved
significantly by 27.1% to EUR 6.1 million.

In summary, the Semperit Group generated earnings after tax amounting
to EUR 10.1 million (after EUR 12.6 million) in the first quarter of
2016. This decline compared with the same period of the previous year
was primarily due to negative foreign currency effects as well as
higher interest expenses.

Outlook 2016 In 2016, Semperit expects no significant changes of the
market conditions compared to 2015. The generally low demand in the
Industrial Sector in 2015 is expected to continue in 2016 due to the
economic situation. In particular in Eastern Europe and Russia, no
economic recovery is to be expected. Neither does the industrial
capital investment cycle show any signs of an upturn, especially in
China. However, demand in the economically insensitive Medical Sector
is expected to develop steadily with a market growth of 5% to 6%.

Nevertheless, Semperit looks at the year 2016 with a certain amount
of confidence and expects a largely stable development in 2016
compared to 2015. In the first months of 2016 Semperit has seen a
continuing good order situation due to intensive marketing and sales
activities in the Industrial Sector. The Medical Sector will profit
from the step-by-step commissioning of new production capacities in
Kamunting, Malaysia, in 2016 and beyond.

The Semperit Group will continue its growth strategy consistently in
2016. The focus will be on the entering into new markets in the
Industrial Sector and the expansion and optimisation of existing
production capacities. In the Medical Sector the focus will be set on
the expansion of the glove production in Malaysia in addition to
further production optimisations, efficiency enhancements and
marketing activities. Altogether, capital investments (CAPEX) of
approximately EUR 70 million are planned for 2016.

As of now the report on the first quarter of 2016 is available at
www.semperitgroup.com/en/ir.

About Semperit The publicly listed company Semperit AG Holding is an
internationally-oriented group that develops, produces, and sells in
more than 100 countries highly specialised rubber products for the
medical and industrial sectors: examination and surgical gloves,
hydraulic and industrial hoses, conveyor belts, escalator handrails,
construction profiles, cable car rings, and products for railway
superstructures. The headquarters of this long-standing Austrian
company, which was founded in 1824, are located in Vienna. The
Semperit Group employs more than 7,000 people worldwide, including
close to 4,100 in Asia and more than 800 in Austria (Vienna and
production site in Wimpassing, Lower Austria). The Group has 22
manufacturing facilities worldwide and numerous sales offices in
Europe, Asia, Australia and America. In 2015 the group generated
sales of EUR 915 million and an EBITDA of EUR 96 million.

Further inquiry note:
Martina Büchele
Group Head of Communications
Tel.: +43 676 8715 8621
martina.buechele@semperitgroup.com
www.semperitgroup.com

Stefan Marin
Head of Investor Relations
Tel.: +43 676 8715 8210
stefan.marin@semperitgroup.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

company: Semperit AG Holding
Modecenterstrasse 22
A-1030 Wien
phone: +43 1 79 777-210
FAX: +43 1 79 777-602
mail: investor@semperitgroup.com
WWW: www.semperitgroup.com
sector: Synthetics & Plastics
ISIN: AT0000785555
indexes: WBI, ATX Prime, ViDX, Prime Market, ATX Global Players
stockmarkets: official market: Wien
language: English